Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

Applied Regression Analysis and Other Multivariable Methods

Esteban Walker, David G. Kleinbaum, Lawrence L. Kupper et al. · Technometrics · 1989 · 8.4K citations

Natural Sciences, Biostatistics, Causal Inference +16

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

Jan P. Vandenbroucke, Ted Koster, Frits R. Rosendaal et al. · The Lancet · 1994 · 1.1K citations

Medicine, Hematology, Obstetrics +17

Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

Hershel Jick, Susan S. Jick, Michael W. Myers et al. · The Lancet · 1995 · 735 citations

Medicine, Endocrinology, Obstetrics +17

Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk

Pierre‐Yves Scarabin, Emmanuel Oger, Geneviève Plu‐Bureau · The Lancet · 2003 · 710 citations

Medicine, Endocrinology, Pharmacotherapy +14

Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study

The Lancet · 1995 · 507 citations · Full text

Medicine, Gynecology, Obstetrics +16